Changes to our company portfolio – MSD and Organon & Co. read more

Changes to our company portfolio

Please note that as of June 3rd 2021, MSD completed the spin-off of products from its women’s health, legacy brands, and biosimilars franchises into the new independent, publicly traded company Organon & Co.

For information on former MSD products now transferred to Organon & Co. please visit their website.

Your questions answered:How MSD is responding to the global pandemic, COVID-19

COVID-19 is an extraordinary challenge to the global community. In the face of this unprecedented challenge, we would like to extend our sincere appreciation to all those who are going above and beyond to do their part in helping affected patients and communities, especially the NHS, healthcare workers and volunteers who are on the front-line of this fight.

As a company dedicated to saving and improving lives, MSD recognises that we have a special responsibility to help. MSD remains focused on protecting the safety of its employees and their families, assuring the supply and manufacture of medicines and vaccines for our patients and populations, contributing our scientific expertise to the development of antiviral approaches, and supporting our healthcare providers and the communities in which they serve.

Thanks to our teams and colleagues, our manufacturing plants and clinical supply sites remain open around the world and, we are taking steps to make sure that continues to be the case.

We know many of you have questions and we want to answer them as best as we can. To help you navigate your questions, we’re providing the list of FAQs below:

Does MSD have medicines or vaccines for COVID-19? If not, is MSD developing any medicines and vaccines to help combat COVID-19?
How is COVID-19 impacting MSD clinical trials?
How is MSD protecting employees and health care providers?
How is MSD supporting relief efforts for COVID-19?
How do we reach the media team at MSD?
How can we stay up to date on COVID-19?
How can I find out more about product supply?

Job code: GB-NON-03884Date of preparation: February 2021

  • News Room